Affimed to Present at the Leerink Partners Global Healthcare Conference 2025

Core Viewpoint - Affimed N.V. is actively participating in the Leerink Partners Global Healthcare Conference 2025, highlighting its commitment to advancing immuno-oncology and engaging with investors [1][2]. Company Overview - Affimed N.V. is a clinical-stage immuno-oncology company focused on empowering patients to combat cancer by harnessing the innate immune system [3]. - The company develops innate cell engagers (ICE) that target and eliminate various hematologic and solid tumors, utilizing its proprietary ROCK platform to create customized molecules [3]. - Affimed is headquartered in Mannheim, Germany, and is led by a team of experienced biotechnology and pharmaceutical professionals dedicated to innovative cancer treatments [3]. Event Details - The CEO, Dr. Shawn Leland, will participate in a fireside chat at the conference on March 11, 2025, at 2:20 p.m. Eastern Daylight Time [1]. - A live webcast of the presentation will be available on Affimed's website, with a replay accessible for 30 days post-event [2].